Hualu Network Group
中文版
search
Home Page
About us
Our Values
Development Milestone
News
News
Products
Product List for API
Recommended API
Product List for Finished Drug
Product list for Chemicals and Intermediates
Contract Manufacturing
API and Pharmaceutical Intermediates
OTC and Generics
Investor Relation
PERIODIC REPORT
INTERIM REPORT
INVESTORS SERVICE
Contact Us
Contact Us
Investor Relation
Information transparency and trust in peers
Investor Relation
PERIODIC REPORT
INTERIM REPORT
INVESTORS SERVICE
PERIODIC REPORT
Home Page
/
Investor Relation
/
PERIODIC REPORT
28
2026-04
Unaudited First Quarter Results of 2026
28
2026-04
2025 Environmental, Social and Governance Report
28
2026-04
2025 Annual Report
27
2026-03
Announcement for 2025 Annual Results
24
2025-10
Unaudited Quarterly Results Announcement ForThe Nine Months Ended 30 September 2025
Unaudited Quarterly Results Announcement ForThe Nine Months Ended 30 September 2025
25
2025-09
2025 Interim Report
02
2025-07
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 June 2025.pdf
06
2025-06
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2025
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2025
14
2025-05
Proxy Form for 2024 Annual General Meeting
14
2025-05
Proxy Form for 2024 Annual General Meeting
Proxy Form for 2024 Annual General Meeting
总条数:
23
条
＜
1
2
3
＞
跳转到:
页
跳转
Copyright © Shandong Xinhua Pharmaceutical Co., Ltd
鲁ICP备09066031号
鲁公安备案号 3703900200041
(鲁)-非经营性-2015-0068
Technical Support:CR DIGITAL
Xinhua Pharmaceutical
